Skip to content

A Pilot Randomized Controlled Trial of a Code-Based Scanning Intervention to Improve Medication Adherence among Patients with Pulmonary Tuberculosis

A Pilot Randomized Controlled Trial of a Code-Based Scanning Intervention to Improve Medication Adherence among Patients with Pulmonary Tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125815
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Code-Based Scanning Intervention Group:The Code-Based Scanning Intervention will be implemented in addition to routine standardized tuberculosis management. This intervention introduces a medication r
Electronic Pillbox Intervention Group:The Electronic Pillbox Intervention will be implemented in addition to routine standardized tuberculosis management. Participants will be provided with an electro

Sponsors

Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with newly diagnosed active pulmonary tuberculosis, confirmed by bacteriological evidence or clinical diagnosis, who are scheduled to initiate standardized anti-tuberculosis treatment, including primary pulmonary tuberculosis, hematogenous disseminated pulmonary tuberculosis, secondary pulmonary tuberculosis, tracheobronchial tuberculosis, and tuberculous pleurisy; 2. Aged >=18 years old; 3. Possession of a smartphone and the ability to scan codes, ensuring adequate understanding of and engagement with the code–based intervention; 4. No history of severe psychiatric disorders or visual, auditory, language, or intellectual impairments that would interfere with study participation.

Exclusion criteria

Exclusion criteria: 1. Patients with extrapulmonary tuberculosis only who do not require standard first-line oral anti-tuberculosis therapy; 2. Patients who are expected to be transferred to another hospital or to relocate outside the study area within one month and are unlikely to complete follow-up; 3. Patients who are currently participating in other intervention trials strongly related to medication adherence and whose interventions are not compatible with the present study.

Design outcomes

Primary

MeasureTime frame
medication adherence;

Secondary

MeasureTime frame
Cure;Treatment completed;Treatment failure;Treatment success;Lost to follow-up;Not evaluated;Death (from any cause);Health-related quality of life;Acceptability, feasibility, adaptability;Adoption;Fidelity;Cost;

Countries

China

Contacts

Public ContactDong Xu

Southern Medical University

romanxu@gmail.com+86 139 1098 8979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026